自体荧光
乳腺癌
荧光
免疫组织化学
活检
近红外光谱
病理
医学
显微镜
荧光寿命成像显微镜
材料科学
癌症
化学
生物医学工程
生物
内科学
光学
物理
神经科学
作者
Shasha Li,Xin Qi,Yuan Li,Huizhen Ma,Haoyue Yan,Siyu Ao,Hongwei Li,Qi Wang,Zhidong Wang,Pengfei Liu,Hao Wang,Xiaodong Zhang
出处
期刊:Nano Letters
[American Chemical Society]
日期:2024-08-09
卷期号:24 (33): 10337-10347
被引量:16
标识
DOI:10.1021/acs.nanolett.4c02945
摘要
Breast cancer (BC) is the most common tumor worldwide and requires crucial molecular typing for treatment and prognosis assessment. Currently, approaches like pathological staining, immunohistochemistry (IHC), and immunofluorescence (IF) face limitations due to the low signal-to-background ratio (SBR) and high tumor heterogeneity, resulting in a high misdiagnosis rate. Fluorescent assay in the second near-infrared region (NIR-II, 1000–1700 nm) exhibits ultrahigh SBR owing to diminished scattering and tissue autofluorescence. Here, we present a NIR-II strategy for accurate BC molecular typing and three-dimensional (3D) visualization based on the atomically precise fluorescent Au 24 Pr 1 clusters. Single-atom Pr doping results in 3.9-fold fluorescence enhancement and long-term photostability. The Au 24 Pr 1 clusters possess high fluorescence centered at ∼1100 nm and the SBR on pathological section diagnosis was 4 times higher than that of NIR-I imaging. This enables high spatial resolution 3D visualization of biopsy specimens, which can surmount tissue heterogeneity for clinical diagnosis of BC.
科研通智能强力驱动
Strongly Powered by AbleSci AI